Valine

Valine

SCHEMBL7133166

CC(C)[C@H](N)C(=O)O.CCC(C)(C)C(=O)O

nearest known ligand 0.60

Full drug profile on Sugi Atlas →

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
SLC7A5 Q01650 2/20 0.60
SLC1A2 P43004 5/20 0.35
SLC1A1 P43005 5/20 0.35
SLC1A3 P43003 4/20 0.35
ALDH1A1 P00352 1/20 0.34
MAPT P10636 1/20 0.34
PTGS1 P23219 1/20 0.34
ACACB O00763 1/20 0.32
ACACA Q13085 1/20 0.32
RIPK1 Q13546 1/20 0.32
USP2 O75604 1/20 0.31
SLCO1B1 Q9Y6L6 1/20 0.31
GRIK1 P39086 1/20 0.31
GRIK2 Q13002 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Valine SCHEMBL8574768 0.80 SLC7A5 (0.60) SLC7A5SLC1A2SLC1A1SLC1A3ALDH1A1
Valine SCHEMBL8574766 0.80 SLC7A5 (0.60) SLC7A5SLC1A2SLC1A1SLC1A3ALDH1A1
Valine SCHEMBL717780 0.79 SLC7A5 (0.71) SLC7A5SLC1A2SLC1A1SLC1A3ALDH1A1
Valine SCHEMBL717779 0.79 SLC7A5 (0.71) SLC7A5SLC1A2SLC1A1SLC1A3ALDH1A1
Valine SCHEMBL161003 0.78 SLC7A5 (0.79) SLC7A5SLC1A2SLC1A1SLC1A3USP2
Valine SCHEMBL3967257 0.78 SLC7A5 (0.79) SLC7A5SLC1A2SLC1A1SLC1A3USP2
Valine SCHEMBL11876966 0.78 SLC7A5 (0.79) SLC7A5SLC1A2SLC1A1SLC1A3USP2
Valine SCHEMBL27571970 0.78 SLC7A5 (0.88) SLC7A5SLC1A2SLC1A1SLC1A3ALDH1A1
Valine SCHEMBL15602719 0.78 SLC7A5 (0.88) SLC7A5SLC1A2SLC1A1SLC1A3ALDH1A1
Valine SCHEMBL8516 0.78

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6506929-B1 Selectively reducing carbonyl function of lactone moiety of lovastatin to hemiacetal, methylating with strong base and methyl iodide in inert solvent, oxidizing product to give simvastatin APOTEX INC. (CA) 2003-01-14 US disclosed
EP-1087958-B1 PROCESS TO MANUFACTURE SIMVASTATIN AND INTERMEDIATES APOTEX INC (CA) 2002-09-04 EP disclosed
EP-1087958-A1 PROCESS TO MANUFACTURE SIMVASTATIN AND INTERMEDIATES APOTEX INC. (CA) 2001-04-04 EP disclosed
WO-1999065892-A1 PROCESS TO MANUFACTURE SIMVASTATIN AND INTERMEDIATES APOTEX INC. (CA) 1999-12-23 WO disclosed